Hyderabad, April 25, 2026:
Green Circuit has emerged as the winner of the TiE Young Entrepreneurs (TYE) Regional Finals 2026 and will represent Hyderabad at the TiE Global Stage.

TiE Young Entrepreneurs (TYE) is a global entrepreneurship education program for high school students (Grades 9–12), run by The Indus Entrepreneurs (TiE). The program goes beyond theoretical learning, enabling students to develop real-world business ideas and transform them into startup ventures.

At the regional finals held at iCollab, Near Niloufer Cafe, Madhapur, Green Circuit stood out among four competing teams with its eco-friendly initiative aimed at reducing electronic waste through accessible recycling solutions. The team comprises Ishika Reddy, Shloka Katuri, Dinesh, and Alekya.

 

With this win, Green Circuit will now represent Hyderabad at the India Finals to be held in Kerala. The winner of the India Finals will advance to the Global Stage in Seattle, USA. While the global winner may not receive direct funding, the platform offers invaluable exposure, recognition, experience, and certification.

Homicare secured the first runner-up position for its innovative platform connecting patients—especially elderly and immobile individuals—with qualified doctors for home visits or virtual consultations. The team includes Deva Simha Reddy, Sushruth Reddy, Akhila, and Yuvan.

Healix was recognized as the second runner-up for its concept of redesigning everyday objects to enhance human interaction, particularly in spaces where people spend most of their waking hours.

The event was graced by Chief Guest Y.V. Rajasekhar Babu, Managing Director of People Combine, along with Murali Kakarla, President of TiE Hyderabad and Founder & CEO of Innobox Systems Pvt Ltd; Ravi Chennupati, Vice President, TiE Hyderabad and Managing Director of Ezone Security Solutions; and Shanthala Veigas, Senior Director, TiE Hyderabad. Jury members Deepti Gaddam, Nagabharana, and Mir Ali felicitated the winners and runners-up.

Addressing an audience of over 100 attendees, Rajasekhar Babu, founder of Oakridge, shared insights from his entrepreneurial journey. He emphasized that today’s students have unprecedented opportunities alongside significant challenges. “Technology is now democratized and accessible to all. Unlike earlier times when companies like Microsoft and Google began in garages, today starting a venture requires not capital, but a strong idea,” he said.

Highlighting the importance of innovation, he added, “Better innovation leads to lesser competition. Innovation stems from empathy—understanding real-world problems and addressing them meaningfully.” Encouraging students to embrace setbacks, he noted, “Failure is not the opposite of success; it is part of the process. Fail early, fail fast, and fail cheap.”

He further urged aspiring entrepreneurs to aim for excellence by creating high-quality products at affordable prices while ensuring customer satisfaction and profitability, citing examples like Maruti 800 and McDonald’s.

In his opening remarks, Murali Kakarla encouraged students to take their ideas seriously and work towards structuring and building them effectively. “It is okay to fail. What matters is the learning and persistence,” he said. He added that since its inception in 2013, TYE has nurtured numerous young entrepreneurs, with TiE Hyderabad enabling over 100 budding entrepreneurs to participate at the global stage.

Business Wire India

 

Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%.

 

This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges.

 

 

Customers with questions or to discuss a specific situation should contact their account representative.

 

 

About PMC Group
PMC Group is a growth-oriented, diversified, global chemicals and plastics company delivering innovative solutions to everyday needs in a broad range of end markets including plastics, consumer products, electronics, paints, packaging, mining, personal care, food, automotive and pharmaceuticals. PMC was built on a sustainable model of growth through innovation while promoting social good. Dedicated to sustainability, PMC derives over half of its raw materials from renewable sources, operating from a worldwide network across the Americas, Europe and Asia. Learn more at www.pmc-group.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260424142135/en/

 

Business Wire India

 

Today, the Higher Regional Court of Frankfurt upheld the February 2025¹ partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/

 

 

 

Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.”

 

The Product in Dispute

 

 

The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into an innovative treatment for rare blood cancers, particularly polycythemia vera, through a comprehensive clinical trial program. This makes BESREMi® the best investigated interferon in clinical trials in this indication as documented in the major relevant guidelines². AOP Health had acquired the rights for both BESREMi®’s development and commercialization in the European, Commonwealth of Independent States (CIS), and Middle Eastern markets from PharmaEssentia in 2009. In its seventh year after its approval by European Medicines Agency (“EMA”), AOP Health has successfully made BESREMi® available to an estimated 12,600 patients in AOP Health’s licensed territory.

 

 

First Arbitration and Set-aside Proceedings

 

 

Since 2017, PharmaEssentia repeatedly attempted to terminate its agreement with AOP Health regarding BESREMi®. In October 2020, an ICC Arbitral Tribunal rejected these attempts and awarded AOP Health approx. EUR 143 million in damages and dismissed PharmaEssentia’s counterclaims in its entirety.

 

 

Subsequent set-aside proceedings confirmed the arbitral award in its essentials, but found procedural flaws with respect to damage quantification, impacting the damages awarded.

 

 

Second Arbitration

 

 

In November 2020, PharmaEssentia initiated a legal action against AOP Health, alleging damage claims. AOP Health in turn claimed damages for delays in BESREMi®’s European approval caused by PharmaEssentia, and the misuse of AOP Health’s clinical trial data for PharmaEssentia’s US marketing authorization. The result was a partial final ICC arbitral award in favor of AOP Health, received on 17 February 2025, which found PEC guilty of intentional breaches and liable for several claims. The tribunal’s decision on the quantum of those claims is yet to be made.

 

 

Ruling of Higher Regional Court of Frankfurt Confirms AOP Health’s Position

 

 

In May 2025, PharmaEssentia filed an application with the Frankfurt Higher Regional Court to set aside the partial final ICC arbitral award dated 10 February 2025, arguing among other things that the award violated public order and PharmaEssentia’s right to be heard.

 

 

On 24 April 2026, the Frankfurt Higher Regional Court dismissed this application in its entirety and declared the award enforceable. An appeal to the German Federal Court of Justice is possible.

 

 

AOP Health believes this decision confirms its position and reinforces its commitment to patients. The company will continue to supply patients in need of ropeginterferon alfa-2b (BESREMi®), maintaining the high standards of quality patients depend on.

 

 

About BESREMi®

 

 

BESREMi® is the first interferon that was approved for polycythemia vera, a myelo­proliferative neoplasm (MPN), indicated in the European Union as monotherapy in adults for treatment of polycythemia vera without symptomatic enlarged spleen. Its overall safety and efficacy were demonstrated in multiple clinical studies.

 

 

BESREMi® (ropeginterferon alfa-2b) is a long-acting, mono-pegylated proline interferon (ATC L03AB15). It is administered once every 2 weeks initially, or up to every 4 weeks after stabilization of blood values. BESREMi® is designed to be self-administered subcutaneously with a pre-filled pen.

 

 

For the EMA Summary of Product Characteristics please visit: BESREMi®

 

 

About AOP Health

 

 

AOP Health is a global healthcare group with roots in Austria, where the headquarters of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) is located. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine.

 

 

At the end of 2024, AOP Health received its first U.S. FDA approval for Rapiblyk^TM, a medication aimed at patients in intensive care units, thereby further strengthening its commitment to making therapies available for patients worldwide. The AOP Health Group has established itself internationally as a pioneer in integrated therapy solutions and operates worldwide through subsidiaries, representations, and a strong network of partners.

 

 

With the claim “Needs. Science. Trust.” the AOP Health Group emphasizes its commitment to research and development, as well as the importance of building relationships with physicians and patient advocacy groups to ensure that the needs of these stakeholders are reflected in all aspects of the AOP Health Group’s actions.

 

 

¹https://www.aop-health.com/global_en/press/press-releases/icc-arbitral-tribunal-ruling-aop-health/

 

 

² ELN Guideline (2022), NCCN Guideline (2024), Onkopedia Leitlinie (2023)

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260424005227/en/

 

Business Wire India

 

At the 2026 Beijing International Automotive Exhibition (“Auto China 2026”), OS and AI technology company Banma Intelligence and Alipay today launched a new AI cockpit solution integrating Alipay AI Pay, enabling drivers to complete purchases by voice command directly from their vehicle.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424618328/en/

 

 

 

“In the past two years, smart cockpits have achieved rapid advances in perception and decision-making,” said Ming Cai, Banma Intelligence Chief Product Officer. “With large models onboard, vehicles can understand user intent and make recommendations. By integrating Alipay AI Pay into our AI cockpit solution, we are removing the last friction point in the in-car smart cockpit experience – drivers simply speak to pay, no phone required.”

 

The new AI cockpit solution initially covers two high-frequency use cases: entertainment and travel. With just a voice command, drivers can seamlessly access AI-powered services to purchase tickets, book hotels, and order food. For example, utilizing Banma Intelligence’s Yan AI and Alipay AI Pay’s capabilities, drivers can initiate a transaction by saying “help me buy two movie tickets.” The AI cockpit system can select showtimes and seats, with drivers able to complete payment by voice confirmation.

 

 

Alipay’s security capabilities, including multi-layered risk management and real-time anti-fraud measures, also safeguard every transaction.

 

 

The solution comes at a time when intelligence has become a key focus area for major automakers. As a key component of in-car services, payment plays a crucial role in enhancing the intelligent user experience, with both automotive system providers and automakers able to integrate their services with Alipay AI Pay. The new AI cockpit solution has completed technical integration testing with major automotive OEMs, who plan to roll out this feature in their new models in the second half of 2026.

 

 

Alipay AI Pay is an AI-native payment solution introduced in 2025 that enables secure, seamless transactions through AI agents via voice command. Alipay AI Pay surpassed 100 million users in February 2026, becoming the world’s first AI-native payment product to reach this milestone. During the week of February 5-11, 2026, it processed over 120 million transactions.

 

 

As agentic commerce grows in China, Alipay AI Pay has expanded across a range of use cases — from AI agents embedded in apps and mini programs for traditional retailers such as Luckin Coffee, to AI smart glasses such as Rokid’s, consumer-facing AI applications like Alibaba’s Qwen and OpenClaw-type AI agents.

 

 

About Alipay

 

 

As the world becomes increasingly digital, Alipay has evolved from a trusted e-wallet into an all-in-one digital platform for daily services, connecting more than one billion consumers to over 80 million merchants across China. Alipay offers users a secure, seamless mobile payment experience and integrates over 10,000 services across sectors like travel, healthcare, tourism, and entertainment. With digital tools like Alipay Tap!, mini-programs, lifestyle accounts, Alipay enables merchants, institutions, and independent software vendors (ISVs) to enhance operational efficiency and effectiveness. In addition, Alipay is developing a new AI-driven open platform by integrating AI agents to deliver smarter, more personalized services to its users as well as facilitating the digital transformation of the service sector.

 

 

About Banma Intelligence

 

 

As the only company that seamlessly integrates the three core pillars of intelligent vehicle experience—system-level OS solutions, full-stack end-to-end AI solutions, and vehicle platform services—into a differentiated intelligent cockpit business model, Banma Intelligence continues to lead industry innovation. Banma Intelligence has established partnerships with 69 automotive OEMs, with its intelligent cockpit solutions deployed in over 10 million vehicles. As a pioneer of an AI-native intelligent cockpit service ecosystem, Banma has onboarded more than 100 service providers. It also works closely with more than 10 leading chip companies to build an open and collaborative chip ecosystem. With full-stack AI capabilities and system-level OS solutions, Banma enables its customers to efficiently bring AI-powered intelligent cockpit features to market, accelerating product deployment and commercialization. Bama Intelligence is committed to leading the world in shaping automotive intelligence and beyond—where OS meets AI to transform the industry.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260424618328/en/

 

Business Wire India

 

Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced new enhancements across several of its product lines. These updates further strengthen Spatial’s commitment to delivering high-performance solutions that optimize interoperability, data preparation, and advanced modeling workflows.

 

Designed to improve efficiency and robustness across CAD translation, modeling, meshing, and simulation processes, the latest updates introduce expanded format support, enhanced PMI handling, and new capabilities for complex geometry processing.

 

 

3D InterOp

 

 

NX Reader Enhancement for 2D Drawings

 

 

The NX reader imports 2D drawings as visualization data from NX 2412 and later versions.

 

 

glTF Writer Supports Draco Compression

 

 

glTF export incorporates Draco compression for meshes and point-clouds to significantly reduce output file sizes.

 

 

Enhanced Support for Reading Product Manufacturing Information (PMI)

 

 

• The STEP Reader supports graphical PMI at the assembly level.
• The JT Reader supports semantic PMI at the assembly level.
• The NX Reader supports PMI created in drafting mode when attached to a solid (PMI attached to drawing sheets are excluded).

 

 

Updated CAD Format Version Support

 

• JT 10.11
• NX 2512
• Solid Edge 2026

 

Data Prep

 

Hidden Body Removal (HBR)

 

 

HBR extends support for assembly models within UConnect workflows to several CAD formats like Solid Edge and Revit as well as for mesh formats like 3MF, OBJ and Smart 3D.

 

 

3D ACIS Modeler

 

 

Blending (Filleting) Enhancements

 

 

• Rho-Conic Cross-Sections: Create blends with conic cross-sections defined by a rho-parameter.
• Enhanced robustness when simultaneously processing multiple edge sequences: Improves stability and prevents overlaps and interference between blends.

 

 

Resolution of Edge Self-Intersections

 

Enable checking and optional splitting of edges with self-intersections.

 

 

Mesh Prep for ACIS

 

 

Mesh Prep for ACIS is an add-on for ACIS that provides tools to simplify the pre-processing of CAD geometry for simulation workflows. Enhancements in Mesh Prep for ACIS for computing centerlines include:

 

 

• Handling of Concentric Faces
  For pipes with concentric inner and outer walls, ACIS now calculates a unique centerline automatically.

 

• Joints and Branches
  Generation of centerlines now handles more complex cases with joints and branches.

 

Mesh Prep for ACIS requires an additional license.

 

3D CGM Modeler

 

 

Curve Self-Intersection Checker

 

 

Detects self-intersections of a curve and optionally splits them to obtain a wire body with the same shape as the input curve in scenarios where a surface on which the input curve lies is known.

 

 

Filleting Aids

 

 

Documentation improvements including new sample code are available that provide more clarity and guidance for the creation of fillets.

 

 

CSM Surface Mesher and CVM Volumetric Mesher

 

 

CSM: Mesh Healing

 

 

Mesh healing functionality in CSM enables robust downstream simulation workflows. The operator prepares for volume meshing by automatically resolving invalid intersections, self-intersections or gaps in the input surface mesh.

 

 

CSM-CVM: Interface for Mesh-Quality Evaluation

 

 

A new mesh quality evaluator enables surface and volume mesh analysis via predefined or custom quality metrics.

 

 

CSM-CVM: Samples for Adaptive Meshing

 

 

Documentation and package enhancements, including new samples, are available for adaptive surface and volume meshing workflows.

 

 

About Spatial Corp.

 

 

Spatial Corp., a Dassault Systèmes subsidiary, is the leading provider of 3D software development toolkits for technical applications across a broad range of industries. Spatial 3D modeling, CAD translation, Meshing and 3D visualization software development toolkits help application developers deliver market-leading products, maintain focus on core competencies, and reduce time-to-market. For over 35 years, Spatial’s 3D software development toolkits have been adopted by many of the world’s most recognized software developers, manufacturers, research institutes, and universities. Headquartered in Broomfield, Colorado, Spatial has offices in the USA, France, Germany, Japan, China, and the United Kingdom. For more information on Spatial’s latest updates and product offerings, please visit www.spatial.com.

 

 

 

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260424111656/en/